A breakthrough new treatment that is currently being tested successfully on rodents, promises tumour termination with one ...

Limited to estrogen receptor-positive breast cancer (ER+) the compound addresses many common concerns with existing treatment ...

The malfunctioning mitochondria seem to poison the immune cells, explains Yosuke Togashi, a pulmonary physician and ...

Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment ...

Nanovaccine achieved tumour inhibition rate of 89.3 per cent when tested on mice with aggressive form of the disease, study finds.

A study by DKFZ researchers shows that inhibiting the enzyme aldolase A in glycolysis traps energy in liver cancer cells, ...

Effectively killed multiple human ER+ breast cancer cell lines in culture. Was well tolerated, with no obvious deleterious effects, by multiple species (mice, rats and beagles). Shrank ...

The typical treatment for estrogen receptor positive (ER+) breast cancer involves surgery and years of hormone therapy that ...

According to the World Health Organization (WHO), in 2022, there were 2.3 million women diagnosed with breast cancer and 670 ...

Researchers at the Crick have uncovered which genes on the Y chromosome regulate the development of sperm and impact ...

Salk scientists have found that eliminating the bile acid-producing protein BAAT and supplementing with the bile acid UDCA ...